Evidence map›Paper›PMID 33815416›Full record

ArticleFrontiers in immunology2021

Human PD-1

Kazuhiko Higashioka, Motoki Yoshimura, Takahide Sakuragi, Masahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, Nobuyuki Ono, Yojiro Arinobu, Makoto Kikukawa, Hisakata Yamada and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. 3-in-oneiScience · 2025
    Article
  3. Pathogenic Role of Cytokines in Rheumatoid Arthritis.Journal of clinical medicine · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. An angel or a devil? Current view on the role of CD8Journal of translational medicine · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kazuhiko HigashiokaDepartment of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Motoki YoshimuraDepartment of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takahide SakuragiDepartment of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Masahiro AyanoDepartment of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yasutaka KimotoDepartment of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
Hiroki MitomaDepartment of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nobuyuki OnoDepartment of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yojiro ArinobuDepartment of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Makoto KikukawaDepartment of Medical Education, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hisakata YamadaDepartment of Arthritis and Immunology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takahiko HoriuchiDepartment of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
Koichi AkashiDepartment of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hiroaki NiiroDepartment of Medical Education, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kyushu University · JPKyushu University Beppu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rheumatoid arthritis (RA) is a prototypical autoantibody-driven autoimmune disease in which T-B interactions play a critical role. Recent comprehensive analysis suggests that PD-1 Methods: CD8 Results: IL-21-producing CD8 Conclusions: Identification of IL-21-producing PD-1

Indexed as

Arthritis, RheumatoidBiomarkersB-Lymphocyte SubsetsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell CommunicationCytokinesDisease SusceptibilityHumansImmunologic MemoryInterleukin-21InterleukinsLymphocyte ActivationProgrammed Cell Death 1 ReceptorT-Lymphocyte SubsetsBiomarkersCytokinesInterleukin-21InterleukinsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorCD8IL-21PD-1rheumatoid arthritisT cells

Identifiers

PMID33815416
PMCPMC8017303
OpenAlexW3139239759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.